Introduction
Current brain-machine interfaces use electrodes placed either on the scalp, surgically implanted onto the surface of the brain, or penetrated directly into the brain to measure neural signals. Measurements of electroencephalography (EEG) performed with electrodes placed directly onto the scalp have been able to demonstrate wilful control of computers and twodimensional movement of a prosthesis with high performance [1] . However, these electrodes are cumbersome, require daily application, and are prone to noise and motion artefacts. Intervening tissues, including the skull, dura, and cerebrospinal fluid, which lie between the electrodes and the brain, also act as temporal and spatial low pass filters, inhibiting the ability of these electrodes to accurately measure and localize the high frequency neural signals responsible for dexterous, thought-induced movement [2, 3] .
To enhance the resolution of cortically generated signals, a portion of the skull can be removed, through which penetrating electrodes are implanted directly into the brain. Penetrating electrodes have been used to achieve threedimensional limb control and self-feeding by monkeys [4] and reach and grasp control of a robotic arm in a paralyzed patient [5] . However, the functional ability of penetrating electrodes for recording single-unit activity degrades over time. Implantation of penetrating electrodes causes the local activation of glial cells and the deposition of astrocytes around the electrodes, with the resulting glial scarring encapsulating electrodes, increasing the electrode impedance and limiting the chronic recording potential [6, 7] . Further, abiotic mechanisms such as electrode decomposition [8] [9] [10] have also been factors that lead to performance reduction and failure of penetrating electrodes.
To position electrodes closer to the brain without inducing deleterious glial responses that prevent acquisition of cortical signals, epidural or subdural arrays are implanted by inserting flat electrode arrays above or below the dura mater through a small burr-hole drilled into the skull. Compared with surface EEG signals, electrocorticography (ECoG) signals measured from these subdural electrodes provides greater spatial resolution [11] , broader bandwidth [12] , increased signal-to-noise ratio [13] and less artefact sensitivity [14] . Using signals acquired by invasive electrodes, it has been shown that tetraplegic patients are capable of three-dimensional cursor control with minimal training [15] [16] [17] [18] . Chronic stability of these electrode arrays has also been demonstrated in animals [19, 20] and humans [21, 22] . The implantation of subdural, epidural, and penetrating arrays, however, requires invasive, open-brain surgery, which carries significant surgical risk (>26%) that may include neurological deficits, wound infections, meningitis, and hemorrhage [23, 24] . The development of an endovascular technique for recording neural information offers a minimally invasive route for recording EEG from deep brain structures [25] .
Using minimally invasive surgical techniques, akin to those commonly applied to remove cerebral arterial thrombus [26] , we have demonstrated that cortical vessels can be utilized to gain access to the brain and the motor cortex [27] . Venous stenting procedures have a technical success rate of 99%, with non-lethal complications occurring in only 2% of cases [28] . We have developed a stent-mounted neural recording device that can be delivered to a cortical venous sinus using minimally invasive, angiographic techniques without requirement for open-brain surgery. Our minimally invasive surgery resulted in a low complication rate, and demonstrated the capacity of our stent-electrode arrays (Stentrodes™) to be chronically tolerated in sheep and able to record high-fidelity neural information [27] .
In this study, we assess and evaluate changes occurring to the stent-mounted electrodes, implanted within a cerebral blood vessel over a chronic period, using electrochemical impedance spectroscopy (EIS). Measurements were taken from animals that had been implanted with devices for up to 190 days [29] . Electrical impedance and phase angle, obtained through sinusoidal excitation of the electrodes across a broad range of frequencies, enabled investigation of tissue and electrode properties [30] . These measurements were fit to simple equivalent circuit models (ECM). Histological measurements of stent incorporation into the blood vessel wall were obtained to investigate the alterations occurring at the electrode-tissue interface.
Methods

Stentrode
TM fabrication and surgical procedure Stent-electrode arrays (Stentrodes™) were fabricated according to methodologies described previously [27] . Between 8 and 12 platinum recording electrodes (750 μm diameter, 50 μm thick) were mounted on a commercially available, self-expanding endovascular stent (Solitaire SAB 20, Covidien, CA, USA). These electrodes were welded to polyimide-insulated platinum-tungsten wire (25 μm diameter) and mounted on the stent strut crosslinks using an ultra-violet curable, biocompatible adhesive (Dymax, 1128A-M, UV Pacific, CT, USA). The wires were carefully wrapped around the stent-head to ensure that the super-elastic and selfexpanding characteristics of the stent were not compromised. A 410 μm diameter stainless steel guide wire, used to assist with Stentrode™ delivery, was attached to the stent-head and used as a mandrel around which the electrode lead wires were coiled and attached to platinum contacts that could be connected to external recording devices.
Electrochemical characterization
Prior to implantation, the stent-mounted endovascular electrodes were cleaned by voltametric cycling to remove fabrication residues from the electrode surface. This was performed in a saline bath in a Gamry 1000 potentiostat (Interface 1000, Gamry Instruments, PA, USA) in a twoelectrode configuration with a −1.5 to 1.5 V potential and a scan rate of 500 mV s −1 for typically 20-40 cycles until the measurements stabilized [31, 32] . The neural recording electrodes were also characterized using EIS prior to deployment. Initial, baseline characterization of the neural recording electrodes was performed using EIS prior to deployment. A two-electrode system in a beaker of physiological saline (0.9% NaCl, Baxter International, IA, USA) with a 10 mV constant voltage perturbation potential was used, referenced to a large platinum return electrode (CH1-115, CH Instruments Inc. USA). As we utilized a constant voltage with small currents passing through the circuit and there was a large impedance difference between the return and Stentrode™ electrodes, the two electrode method was deemed suitable for impedance measurements [33] . The impedance spectra were measured using a sinusoidal input voltage over the range 1 Hz to 1 MHz, with 10 samples per decade. Following implantation in sheep, EIS was performed on days 0, 1, 2, 4, 8, 10, 12, 14 and then weekly thereafter for up to 3 months. The in vivo EIS measurements were performed three times and averaged, using a custom-designed head ground electrode as a return.
Surgical procedure
The surgical procedure to implant and record neural activity from a Stentrode™ has been described previously [27] . In this work, 15 adult (24 years old) Corriedale ewes weighing between 40 and 70 kg were used with approval by the Animal Experimentation Ethics Committee of the Florey Institute of Neuroscience and Mental Health. Animals were anaesthetized with an intravenous injection of 10-15 mg kg −1 sodium thiopentone (Jurox Pty. Ltd, AUS) and ventilated with isoflurane (Delvet, Ceva, AUS). Under anesthesia, the internal jugular vein was exposed and used as a conduit through which to access the superior sagittal sinus. A mobile C-arm image intensifier (Arcadis Avantic, Siemens; Munich, Germany) was used to visualize and guide the telescopic catheter system to the portion of the superior sagittal sinus overlying the motor cortex (figure 1) by capturing x-ray images (venogram) of the vessels following injection of a radiopaque contrast (Omnipaque 240, GE Healthcare, PA, USA). When in the desired motor cortex location over the motor cortex, the Stentrode™ was fed through a 1.04 mm internal diameter delivery catheter (DAC057; Concentric Medical, CA, USA), that was expanded at the deployment site to conform to the vessel wall. Following deployment, the Stentrode™ was connected to an in-house connection block that was tunneled subcutaneously to the base of the neck where it exited through a small wound in the skin. A 25 mm×25 mm×50 μm (total active area of 52.5 mm 2 ) platinum ground electrode was placed subcutaneously on top of the animal's skull, with an additional stainless steel return electrode placed subcutaneously on the animal's back. The animal was then allowed to recover. At experiment completion, euthanasia was performed with a lethal injection of sodium pentobarbitone.
Electrode tissue interface modeling
There have been previous descriptions regarding microelectrode properties and characterization [31, 34, 35] . We extended these models to the devices used in our experiments, utilizing the ECM in figure 2 . Here, R S represents the circuit access resistance, including the cables and wires from the potentiostat to the implanted recording and reference electrodes. The tissue impedance was represented by a parallel resistor-capacitor circuit to model the tissue and fluid resistance, R T , and the capacitance of the encapsulating tissue present between the reference and working electrodes, C T . Together, these elements form a generic Randles cell. The electrode-tissue interface in our ECM, R E , was modelled as the resistance of the 750 μm diameter stent-mounted electrodes in parallel with a double-layer constant phase element, CPE E . This CPE is an approximation to the interfacial capacitance caused by the double layer that forms when electrodes are immersed in an electrolyte [36] . Its deviation from a pure capacitance represents specific adsorption of proteins and surface roughness effects [35, 37, 38] . The non-Faradaic impedance of a CPE is given by the empirical relation
where Q −1 is the impedance magnitude, ω is the angular frequency, and α is the exponent term of the CPE E that represents the inhomogeneties in the electrode surface. When α=1, CPE E acts like a purely capacitive element, and when α=0, like a purely resistive element. The overall system impedance is given by
The system impedance can then be split into a purely resistive component, ¢ Z , and imaginary component,  Z , with phase angle, θ:
The model was fitted to in vivo measurements with Gamry Echem Analyst (6.2.2, Gamry Instruments, USA) using a simplex, least squares method. To identify the tissue resistance, the peak resistance frequency method was employed by identification of the impedance at a phase angle closest to 0° [34] .
Histopathological evaluation
Following sacrifice, the cortex was extracted and dissected to remove excess tissue surrounding the superior sagittal sinus and implanted electrode array. Samples, measuring approximately 5 mm×5 mm×30 mm, were then processed and resin embedded in accordance with methods established previously [27, 29, 39] . Each resin embedded specimen yielded up to 17 sections, with 200-800 μm thick slices taken at 1-1.5 mm intervals. Sections were then mounted to a glass slide (Ward's petrographic microscope slide; Rochester, NY) using cyanoacrylate (Loctite glass glue; Henkel, Germany). Harris' haematoxylin (American MasterTech, USA) was applied directly to the resin-embedded tissue sections for 36 h at 37°C without prior deplasticisation. Images of the stained samples were captured using a Laborlux D light microscope (Leitz, Germany) at 4× magnification, fitted with a Leica DFC320 camera (Germany) and Leica Application Suite V4.2 software. The digital photographs were imported into ImageJ (1.48 V, NIH, USA) and the number of stent-struts present in each image, both covered in neointima and uncovered, were recorded.
Results
Electrochemical characterization
Prior to implantation, cyclic voltammetry (CV) was performed to remove fabrication debris. Through scanning microscopic assessment, the reduction in impedance was visually confirmed to correlate with a removal of debris from the electrode surface; an example is shown in figures 3(A) and (B). Comparison of pre-CV and post-CV electrical impedance spectroscopy demonstrated a decrease in impedance (Z, defined in equation (2)) across all electrodes and at all frequencies (shown in figure 3(C) ), decreasing from 6.26±6.7 kΩ (mean±SD, n=89) to 2.21±1.2 kΩ (n=89 at 1 kHz, and 1.88±1.4 kΩ to 1.12±0.4 kΩ at 10 kHz.
The impedances of 68 electrodes were assessed immediately prior to and following implantation of the Stentrodes™ through the superior sagittal sinus to overlie the motor cortex, as summarized in figure 4 . For seven electrodes, the postimplant impedance was substantially higher than saline bath measurements (>50 kΩ at 1 kHz). On experiment conclusion, it was confirmed that these electrodes were not electrically connected to the percutaneous connector as the lead wires had fractured and, consequentially, electrodes with impedance >50 kΩ at 1 kHz were excluded from further analysis. An additional eight electrodes had in vivo impedances less than 1 kΩ at 1 kHz. It was predicted that these electrodes had become shorted to the stent or the stent shaft, and to confirm this hypothesis, we measured the electrical impedance characteristics of bare stents (with no electrodes or alterations) immersed in saline. The bare stents were observed to have impedances of 0.63±0.02 kΩ (mean±SD, n=12) at 1 kHz, comparable to the impedances of the eight electrodes postulated to have been shorted (0.66±0.1 kΩ; n=8). Consequentially, all electrodes with impedances less than 1 kΩ at 1 kHz were considered to be electrically connected to the stent and were removed from further analyses. Electrodes that were not electrically shorted to the stent and did not have fractured wires were considered viable for recording neural information and formed the Stentrode. For these electrodes, there was a two-fold increase in impedance at 1 and 10 kHz (4.49±2.2 kΩ and 2.15±0.8 kΩ, respectively; n=53).
A linear relationship was observed between pre-and post-implantation impedances across the 53 viable electrodes, with a slope of 1.696 (r 2 =0.695). There was also an observed increase in the peak resistance frequency, from 0.89±0.2 kΩ (mean±SD, n=84) at 200 kHz (phase angle of −5.7°±2.5°) to 1.86±0.9 kΩ (n=53) at 39.9 kHz (phase angle of 18.2°±6.4°), indicative of an increase in solution resistance.
As stent-shaft wires followed the superior sagittal sinus through the mandible to the jugular vein, each time the animal chewed, the stainless steel push-wire used to deliver the electrode array, was fatigued. Complete fracture of this wire was observed in two animals following a routine three-month angiographic assessment. The 10 kHz impedances of these electrodes (5.11±2.2 kΩ; mean±SD, n=19) were similar to the average electrode impedance measurement at day 0 (3.51±3.9 kΩ; n=32) for all other arrays. However, there was a large difference in the 100 Hz phase (defined as θ in equation (5)) between electrodes measured at day 0 (−60.3°±14.5°; n=32) and those from the fractured wires (−17.6°±5.5°; n=19). To ensure electrode wires that had fatigued were not used to evaluate the stability of the electrode-tissue interface, post hoc exclusion of electrodes with 100 Hz phase angles greater than −30°was conducted prior to analysis.
Impedance and phase over time
EIS was performed on animals at days 0, 1, 2, 4, 6, 8, 10, 12, 14, and then weekly thereafter for up to thirteen weeks (figures 5(A) and (B)). From day 0 to day 8, there was a gradual decrease in low frequency impedance (below 1 kHz) and corresponding increase in low frequency phase, which was observed to stabilize at day 8. While a gradual decrease in 1 kHz impedance was observed, decreasing from 3.99±1.5 kΩ (mean±SD, n=52) recorded one day post implantation to 2.28±0.8 kΩ (n=4) recorded on day 91, this was not statistically significant (Student's t-test, p=0.098). This indicates that this measurement alone is not sufficient for evaluation of chronically implanted electrode arrays.
To identify the encapsulation resistance of implanted electrodes, we used a simple isolation technique described by Mercanzini et al [34] , reported to be more accurate than recording 1 kHz impedance measurements only. Here, we identified the frequency at which the electrode-tissue interface was most resistive (phase angle closest to 0°) and identified the corresponding impedance magnitude at this frequency. Results of the peak resistance frequency of our implanted electrodes are shown in figure 5(C) . The highest phase angle remained stable across the 91 day implantation period (−19.3°±8.1°(mean±SD, n=28) at 40 kHz on day 0 to −17.1°±2.0°(n=4) at 40 kHz on day 91). Peak resistance frequency measurements ( figure 5(D) ) were also consistent across the 91 implantation period (1.95±0.7 kΩ on day 0 to 1.21±0.2 kΩ on day 91). There was, however, a large change observed over the initial nine days of implantation when assessing the minimum phase angle. This decreased from −67.8°±8.8°(n=28) at day 0 to −55.0°±12.0°(n=50) at day 2. A stable phase angle was observed after 8 days: −44.0°±7.7°(n=40) at day 8, −38.0°±8.6°(n=9) at day 63, and −43.8°±0.8°(n=4) at day 91. All minimum phase angles occurred at frequencies between 8 and 80 Hz. The electrochemical impedance spectra was observed to stabilize after 8 days, with no substantial changes in impedance or phase observed after this implant duration ( figure 5(A) ); at 1 kHz, impedance magnitude were 7.32±7.1 kΩ at day 0 (n=28), 5.3±3.8 kΩ at day 1 (n=49), 3.87±1.2 kΩ at day 8 (n=31), 2.66±0.9 kΩ at day 63 (n=9), and 2.71±0.2 kΩ at day 91 (n=3).
Circuit model and analysis
The ECM more closely fitted the averaged data from the cohort of animals than the standard Randle's cell across all time points analyzed ( figure 6(A) ). Owing to the small number of animals and electrodes that were housed for durations longer than 63 days (<9 electrodes), models were only fit to average data sets up to durations of 63 days (34±18 (mean±SD) viable electrodes with a range of 9 to 59 viable electrodes). The goodness-of-fit across all time points ( figure 6(B) ), calculated by Garmy Echem software, was 0.0024±0.002 (mean±SD, n=14 time points) and 0.0089±0.006 for our ECM and for the Randle's cell, respectively. Both circuit models were observed to have better fits at later implant durations. Between day 0 and day 63, the ECM showed a 58% reduction in access resistance, R S , from 1.43±0.03 kΩ to 0.60±0.05 kΩ ( figure 6(C) ), a reduction in the resistance of the electrode-tissue interface, R E , from 6300±600 kΩ to 310±56 kΩ, and a reduction in tissue resistance, R T , from 0.91±0.04 kΩ to 0.27±0.05 kΩ. No change over time was observed with respect to the tissue capacitance, C T , (5.42±0.5 pF to 5.58±2.2 pF). The capacitance of the CPE, representing the electrode-tissue interface, CPE E , increased by over 440% from 160±2.6 pF to 7090±220 pF over the 63 day implant duration, with a corresponding decrease in α from 0.78±0.003 to 0.49±0.005.
Histopathological assessment
Histological assessment was conducted on animals that had been implanted with a Stentrode™ over the motor cortex in the superior sagittal sinus for 0, 9, 14, 27, 34, 56, 77, 83, 91, 98, 124, 153, 182, 183, and 190 days (figure 7). It was observed from post-explant histological analyses that the stent-struts became covered in neointimal tissue over the initial 9-14 days, with over 85% of the struts covered after two weeks. Intimal incorporation was observed to cover exposed struts in all animals implanted with a Stentrode, however, there was no case in which the neointima completely occluded the 2-3 mm diameter superior sagittal sinus. Neointimal incorporation was observed to be thickest between 2 and 4 weeks (600±46 μm (mean±SD, n=34) , n=58 at day 13 and 540±48 μm, n=47 at day 27), prior to remaining stable after 34 days with thicknesses of 350±37 μm and 310±18 μm (n=113) at day 190 ( figure 7(c) ). 
Discussion
This work demonstrates the capability of EIS to identify viable electrodes implanted in the superior sagittal sinus of a large animal model.
In the time following implantation, the average impedance measured across all viable electrodes did not significantly change over the 91 day assessment period. Through histological assessment however, neointimal growth over the implanted electrodes and stent struts was clearly observed. Therefore, measurements of impedance alone were not suitable for identification of changes occurring at the electrodetissue interface. Assessment of peak resistance frequency was assessed with expectations that the impedance at the frequency of the maximum phase angle would be able to infer tissue encapsulation [34, 40] . This measure was not shown to predict electrochemical changes to electrodes implanted inside a blood vessel, as there was no significant alteration in peak resistance frequency or impedances measured at these frequencies. Through measurements of phase angle, however, we were able to observe electrochemical changes which have been reported to be a predictor of protein absorption on the surface of electrodes [31, 35] . Low frequency phase angles were used to assess capacitive changes, with phase angles at 100 Hz increasing significantly from day 0 to day 8 (from −67.8°±8.8°to −55.0°±12.0°), and stabilizing thereafter (100 Hz phase angle of 43.8 ±°at day 91). This was similar to observations on sub-retinal electrode arrays [38] , where this change was suggested to be the result of an increase between cell-to-electrode distance. Electrode stability 7-20 days post-implantation has also been reported by groups evaluating penetrating microelectrode arrays [33] [34] [35] , however these implants demonstrated an increase in impedance over the initial 7-20 days, plateauing thereafter.
To further characterize the changes occurring to our electrodes, we constructed simplified circuit models, similar to those described previously [31, [33] [34] [35] . Our model was shown to have a better 'goodness of fit' than generic Randle's cells, which is not surprising given the more realistic addition of components representing tissue resistance and membrane capacitance. These models demonstrated that the access resistance was relatively stable, decreasing only slightly, throughout the implantation period. The tissue resistance also followed a similar trend, decreasing slightly over the 63 day implantation period. There was a significant decrease over the initial 7 days following implantation calculated for the electrode resistance, which stabilized thereafter. This initial decrease in resistivity was likely the result of fluid accumulation around the array resulting from an increase in vascular permeability [40] . The most compelling finding to support the hypothesis of protein absorption on the electrode surface was demonstrated through a significant increase in the capacitance of the CPE over the initial 7 days, and a corresponding decrease in α. Again, these values plateaued 7 days following implantation. Given the capacity of our technology to accurately and chronically measure vascular impedances, it is possible that these devices could be utilized to detect and characterize atherosclerotic plaques in human coronary and other vessels [41] . While the circuit model described was able to accurately predict electrochemical changes, the generation of these changes was also investigated through assessment of histological sections. Sections from animals implanted for up to 190 days showed a very rapid incorporation of stent struts into the vessel, covering more than 85% of the struts with neointima within the first two weeks. This is promising for permanent implantation of a neural recording electrode inside cortical blood vessels, with incorporation of stent-struts a common phenomenon observed in cardiac stenting [42, 43] . This has been reported to reduce the risk of thrombosis by decreasing the amount of bare-metal exposed to the blood stream [44] , while also acting to anchor the electrode array in place. Measurements of strut-to-lumen distance were also measured, and while a large variability was observed both between and within animals, there was no observation in which neointimal proliferation occluded the 2-3 mm diameter superior sagittal sinus. While it is unknown whether this is related to the radial force present between the implanted arrays and the vessel wall, the diameter of the vessels in which the devices were implanted or intrinsic and animal specific features, we did observe that the neointimal thickness stabilized after 34 days. As luminal stabilization has been reported previously to occur after three months [45] and possible sooner in veins [46] , these result indicate that it is unlikely that evaluation over longer time points would demonstrate continued alterations in neointimal proliferation, and, as such, that this device would be suitable for permanent implantation.
Sterilization of electrodes using ethylene oxide, ethanol solutions, gamma irradiation or otherwise are able to ensure that potentially harmful micro-organisms are removed from devices prior to implantation. These techniques however, are not designed to remove fabrication debris, such as glues, from the electrode surface. To remove these materials from the surface of the electrodes, we employed voltammetric cycling. We were able to visualize the reduction of surface contaminants using scanning electron microscopy and quantify the reduction of these materials through measurements of electrochemical impedance, demonstrating a decrease in electrode impedance and a significant reduction in the interelectrode impedance variability. This process enables more accurate identification of electrode changes in vivo, and is recommended. Electrode impedance testing was further employed to identify electrodes that were not electrically isolated from the stent. These electrodes were observed to have an impedance of less than 1 kΩ at 1 kHz in saline, and could therefore be identified and re-insulated prior to implantation. Following implantation, electrode impedances at 1 kHz were observed to increase two-fold, which is consistent with prior observations [47] . While 1 kHz impedance is a commonly used measure for electrode viability, we did not observe any significant in vivo impedance changes between functional electrodes and those that were identified, though x-ray, to have fractured wires at this frequency. We were, however, able to identify electrodes that had been disconnected in vivo by observing changes in phase angle occurring at 100 Hz, with non-functional electrodes having a 100 Hz phase angle of greater than −30°.
Conclusion
The results of this study demonstrate the application of EIS to characterization of electrode-tissue interactions induced by a chronically implanted intravascular electrode array. Over a 91 day period, no significant changes in 1 kHz impedance were observed, although there were significant changes in low frequency phase. Simple circuit models indicated that these interactions were the result of changing capacitance, suggesting protein absorption on the electrode surface. Histological assessment of animals implanted for up to 190 days showed a significant increase in the percentage of stent struts that were incorporated into the vessel wall, which covered over 85% of the stent struts in neointima within the first two week following implantation. This is in good agreement with circuit model analyses and observations of low frequency phase changes identified through EIS. These results suggest that endovascular devices implanted in the superior sagittal sinus over the motor cortex can be chronically tolerated and stabilize 8-14 days following implantation.
